Fenwick represented MRL Ventures on the deal.MRL Ventures, a venture capital fund that invests in early-stage therapeutic companies that transform patient care globally, announced an upsized and oversubscribed $100…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
